Personal Injury Law

FDA Approves Tapentadol Hydrochloride, The First New Drug In Its Class In More Than 25 Years for the Relief of Moderate to Severe Acute Pain

According to the American Pain Foundation, more than 25 million Americans experience acute pain each year as a result of injuries or surgeries, and a recent study estimated that 42 percent of U.S. hospital emergency department visits were due to pain-related problems. Acute pain is a symptom of many medical conditions and can significantly interfere with a person’s quality of life and general functioning. Arthritis is the most common chronic debilitating disease in the United States (more than 43 million people or 1 in 6). Osteoarthritis of the knee is a very common and a major cause of disability. The U.S. Food and Drug Administration (?FDA?), on November 24, 2008, approved Tapentadol hydrochloride, an immediate-release oral tablet for the relief of moderate to severe acute pain, cancer-related and other. A trade name has not yet been established.

Full post as published by Legal Blog on December 01, 2008 (boomark / email).